High dose escalation of intracoronary adenosine in the assessment of fractional flow reserve: A retrospective cohort study.

Maximal hyperaemia for fractional flow reserve (FFR) may not be achieved with the current recommended doses of intracoronary adenosine. Higher doses (up to 720 μg) have been reported to optimize hyperaemic stimuli in small dose-response studies. Real-world data from a large cohort of patients is nee...

Full description

Bibliographic Details
Main Authors: Chien-Boon Jong, Tsui-Shan Lu, Patrick Yan-Tyng Liu, Mu-Yang Hsieh, Shih-Wei Meng, Ching-Chang Huang, Hsien-Li Kao, Chih-Cheng Wu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0240699
_version_ 1819128701843931136
author Chien-Boon Jong
Tsui-Shan Lu
Patrick Yan-Tyng Liu
Mu-Yang Hsieh
Shih-Wei Meng
Ching-Chang Huang
Hsien-Li Kao
Chih-Cheng Wu
author_facet Chien-Boon Jong
Tsui-Shan Lu
Patrick Yan-Tyng Liu
Mu-Yang Hsieh
Shih-Wei Meng
Ching-Chang Huang
Hsien-Li Kao
Chih-Cheng Wu
author_sort Chien-Boon Jong
collection DOAJ
description Maximal hyperaemia for fractional flow reserve (FFR) may not be achieved with the current recommended doses of intracoronary adenosine. Higher doses (up to 720 μg) have been reported to optimize hyperaemic stimuli in small dose-response studies. Real-world data from a large cohort of patients is needed to evaluate FFR results and the safety of high-dose escalation. This is a retrospective study aimed to evaluate the safety and frequency of FFR ≤0.8 after high-dose escalation of intracoronary adenosine. Data were extracted from the medical databases of two university hospitals. Increasing doses (100, 200, 400, 600, and 800 μg) of adenosine were administered as intracoronary boluses until FFR ≤0.8 was achieved or heart block developed. The percentage of FFR ≤0.8 after higher-dose escalation was compared with those at conventional doses, and the predictors for FFR ≤0.8 after higher doses were analysed. In the 1163 vessels of 878 patients, 402 vessels (34.6%) achieved FFR ≤0.8 at conventional doses and 623 vessels (53.6%) received high-dose escalation. An additional 84 vessels (13.5%) achieved FFR ≤0.8 after high-dose escalation. No major complications developed during high-dose escalation. Borderline FFR (0.81-0.85) at the conventional dose, stenosis >60%, and triple-vessel disease increased the likelihood of FFR ≤0.8 after high-dose escalation, but chronic kidney disease decreased it. For vessels of borderline FFR at conventional doses, 46% achieved FFR ≤0.8 after high-dose escalation. In conclusion, High-dose escalation of intracoronary adenosine increases the frequency of FFR ≤0.8 without major complications. It could be especially feasible for borderline FFR values near the 0.8 diagnostic threshold.
first_indexed 2024-12-22T08:32:01Z
format Article
id doaj.art-5bae03fbbfe7422c926dffd0e02932b9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T08:32:01Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5bae03fbbfe7422c926dffd0e02932b92022-12-21T18:32:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011510e024069910.1371/journal.pone.0240699High dose escalation of intracoronary adenosine in the assessment of fractional flow reserve: A retrospective cohort study.Chien-Boon JongTsui-Shan LuPatrick Yan-Tyng LiuMu-Yang HsiehShih-Wei MengChing-Chang HuangHsien-Li KaoChih-Cheng WuMaximal hyperaemia for fractional flow reserve (FFR) may not be achieved with the current recommended doses of intracoronary adenosine. Higher doses (up to 720 μg) have been reported to optimize hyperaemic stimuli in small dose-response studies. Real-world data from a large cohort of patients is needed to evaluate FFR results and the safety of high-dose escalation. This is a retrospective study aimed to evaluate the safety and frequency of FFR ≤0.8 after high-dose escalation of intracoronary adenosine. Data were extracted from the medical databases of two university hospitals. Increasing doses (100, 200, 400, 600, and 800 μg) of adenosine were administered as intracoronary boluses until FFR ≤0.8 was achieved or heart block developed. The percentage of FFR ≤0.8 after higher-dose escalation was compared with those at conventional doses, and the predictors for FFR ≤0.8 after higher doses were analysed. In the 1163 vessels of 878 patients, 402 vessels (34.6%) achieved FFR ≤0.8 at conventional doses and 623 vessels (53.6%) received high-dose escalation. An additional 84 vessels (13.5%) achieved FFR ≤0.8 after high-dose escalation. No major complications developed during high-dose escalation. Borderline FFR (0.81-0.85) at the conventional dose, stenosis >60%, and triple-vessel disease increased the likelihood of FFR ≤0.8 after high-dose escalation, but chronic kidney disease decreased it. For vessels of borderline FFR at conventional doses, 46% achieved FFR ≤0.8 after high-dose escalation. In conclusion, High-dose escalation of intracoronary adenosine increases the frequency of FFR ≤0.8 without major complications. It could be especially feasible for borderline FFR values near the 0.8 diagnostic threshold.https://doi.org/10.1371/journal.pone.0240699
spellingShingle Chien-Boon Jong
Tsui-Shan Lu
Patrick Yan-Tyng Liu
Mu-Yang Hsieh
Shih-Wei Meng
Ching-Chang Huang
Hsien-Li Kao
Chih-Cheng Wu
High dose escalation of intracoronary adenosine in the assessment of fractional flow reserve: A retrospective cohort study.
PLoS ONE
title High dose escalation of intracoronary adenosine in the assessment of fractional flow reserve: A retrospective cohort study.
title_full High dose escalation of intracoronary adenosine in the assessment of fractional flow reserve: A retrospective cohort study.
title_fullStr High dose escalation of intracoronary adenosine in the assessment of fractional flow reserve: A retrospective cohort study.
title_full_unstemmed High dose escalation of intracoronary adenosine in the assessment of fractional flow reserve: A retrospective cohort study.
title_short High dose escalation of intracoronary adenosine in the assessment of fractional flow reserve: A retrospective cohort study.
title_sort high dose escalation of intracoronary adenosine in the assessment of fractional flow reserve a retrospective cohort study
url https://doi.org/10.1371/journal.pone.0240699
work_keys_str_mv AT chienboonjong highdoseescalationofintracoronaryadenosineintheassessmentoffractionalflowreservearetrospectivecohortstudy
AT tsuishanlu highdoseescalationofintracoronaryadenosineintheassessmentoffractionalflowreservearetrospectivecohortstudy
AT patrickyantyngliu highdoseescalationofintracoronaryadenosineintheassessmentoffractionalflowreservearetrospectivecohortstudy
AT muyanghsieh highdoseescalationofintracoronaryadenosineintheassessmentoffractionalflowreservearetrospectivecohortstudy
AT shihweimeng highdoseescalationofintracoronaryadenosineintheassessmentoffractionalflowreservearetrospectivecohortstudy
AT chingchanghuang highdoseescalationofintracoronaryadenosineintheassessmentoffractionalflowreservearetrospectivecohortstudy
AT hsienlikao highdoseescalationofintracoronaryadenosineintheassessmentoffractionalflowreservearetrospectivecohortstudy
AT chihchengwu highdoseescalationofintracoronaryadenosineintheassessmentoffractionalflowreservearetrospectivecohortstudy